![](https://i.imgur.com/CLvY2jA.png")
Covaxin is formulated uniquely such that the same dosage can be administered to adults and children alike, for primary and booster doses, making it truly a universal vaccine, the company release said.
Krishna Ella, chairman, and managing director, of Bharat Biotech, said the team has now demonstrated that Covaxin is a multi-epitope vaccine with antibodies against spike, RBD, and N proteins.
''Post booster dose, it has proven neutralizing antibody responses against variants of concern and long-term protection through memory T and B cell responses. We have now achieved our goal of developing a safe and efficacious vaccine with long-term protection against a spectrum of variants,'' Ella said.
https://www.businesstoday.in/coronavirus...2022-07-20
Krishna Ella, chairman, and managing director, of Bharat Biotech, said the team has now demonstrated that Covaxin is a multi-epitope vaccine with antibodies against spike, RBD, and N proteins.
''Post booster dose, it has proven neutralizing antibody responses against variants of concern and long-term protection through memory T and B cell responses. We have now achieved our goal of developing a safe and efficacious vaccine with long-term protection against a spectrum of variants,'' Ella said.
https://www.businesstoday.in/coronavirus...2022-07-20
